Ordering Recommendation

SurePath media is not preferred when testing for Chlamydia trachomatis and Neisseria gonorrhoeae by transcription-mediated amplification (TMA). Use of transport media other than APTIMA specimen collection kit may result in reduced sensitivity. The preferred test is Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA) (0060241) or if confirmation of positive results by an alternate nucleic acid target is required, refer to Chlamydia trachomatis and Neisseria gonorrhoeae (CTNG) by Transcription-Mediated Amplification (TMA) with Reflex to CT/NG Confirmation (2011164).

Mnemonic
CTNG SP
Methodology

Transcription-Mediated Amplification

Performed

Sun-Sat

Reported

1-4 days

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect

Cervical brush in SurePath liquid-based Pap test Media. Refer to "Sample Collection for the Diagnosis of STD" under Specimen Handling at www.aruplab.com for specific specimen collection and transport instructions.

Specimen Preparation

Vortex SurePath media and transfer 1 mL to APTIMA Specimen Transfer Tube (ARUP supply #42711) within 24 hours of collection. Available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. To reduce the potential for contamination, SurePath specimens should be poured off, using sterile technique, into the APTIMA Specimen Transfer Tube prior to Cytology Testing.

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Specimens in any container other than APTIMA Specimen Transfer Media. Specimens from patients that are less than 16 years of age.

Remarks

Specimen source is required.

Stability

APTIMA Specimen Transfer Tube: Ambient: 2 weeks; Refrigerated: 1 month; Frozen: 1 month

Reference Interval

Negative

Interpretive Data

Use of transport media other than the APTIMA specimen collection kit may result in reduced sensitivity. Specimens should be collected and transported following the instructions in "Sample Collection for the Diagnosis of STD Using Nucleic Acid Amplification Tests" under Specimen Handling at www.aruplab.com.

This test is intended for medical purposes only and is not valid for the evaluation of suspected sexual abuse or for other forensic purposes. In certain contexts, culture may be required to meet applicable laws and regulations for diagnosis of C. trachomatis and N. gonorrhoeae infections. Per 2014 CDC recommendations, this test does not include confirmation of positive results by an alternative nucleic acid target.

Compliance Category

Modified FDA

Note
Hotline History
N/A
CPT Codes

87491; 87591

Components
Component Test Code* Component Chart Name LOINC
2001552 C. trachomatis by TMA, SurePath 50387-0
2001553 N. gonorrhoeae by TMA, SurePath 50388-8
2005507 Specimen Source 31208-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Chlamydia and GC TMA panel
  • CT/GC TMA SurePath
  • Gonorrhea SurePath
  • Nucleic Acid Amplification Test (NAAT)
Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA), SurePath